In order to strengthen Lytix Biopharma`s research program on Oncolytic peptides, the company is collaborating with the international leading experts.

• Guido Kroemer and Laurence Zitvogel, Institute Gustav Roussy, have been central in the discovery of apoptosis, immunogenic cell death and role of the microbioma in cancer treatment.
• Sandra Demaria, Weill Cornell Medical College, New York, has been central in understanding how radiation modulates tumor immunogenicity and improves response to immunotherapy.